DK1668025T3 - Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdom - Google Patents
Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdomInfo
- Publication number
- DK1668025T3 DK1668025T3 DK04789044.7T DK04789044T DK1668025T3 DK 1668025 T3 DK1668025 T3 DK 1668025T3 DK 04789044 T DK04789044 T DK 04789044T DK 1668025 T3 DK1668025 T3 DK 1668025T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- treating disease
- based preparations
- valley virus
- seneca valley
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50618203P | 2003-09-26 | 2003-09-26 | |
PCT/US2004/031504 WO2005030139A2 (en) | 2003-09-26 | 2004-09-23 | Seneca valley virus based compositions and methods for treating disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1668025T3 true DK1668025T3 (da) | 2014-08-25 |
Family
ID=34393123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04789044.7T DK1668025T3 (da) | 2003-09-26 | 2004-09-23 | Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdom |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1668025B1 (da) |
JP (1) | JP2007506434A (da) |
KR (1) | KR20060103890A (da) |
CN (1) | CN1875028B (da) |
AU (1) | AU2004275832A1 (da) |
BR (1) | BRPI0414810A (da) |
CA (1) | CA2540177A1 (da) |
DK (1) | DK1668025T3 (da) |
HK (1) | HK1094583A1 (da) |
IL (1) | IL174430A0 (da) |
MX (1) | MXPA06003318A (da) |
SG (1) | SG149069A1 (da) |
WO (1) | WO2005030139A2 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
US7638318B2 (en) | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
WO2007047256A2 (en) * | 2005-10-13 | 2007-04-26 | Neotropix, Inc. | Svv-based animal vaccines and uses thereof |
CA3045771A1 (en) * | 2015-12-02 | 2017-06-08 | Memorial Sloan-Kettering Cancer Center | Seneca valley virus (svv) cellular receptor targeted oncotherapy |
CN105925728B (zh) * | 2016-06-01 | 2019-09-20 | 华南农业大学 | 一种塞内加谷病毒实时荧光定量pcr检测引物及试剂盒 |
US10323069B2 (en) * | 2016-08-23 | 2019-06-18 | Regents Of The University Of Minnesota | Senecavirus A antigens and methods of use |
CA3069821A1 (en) * | 2017-07-14 | 2019-01-17 | Oncorus, Inc. | Encapsulated polynucleotides and methods of use |
CN109627293B (zh) * | 2017-08-13 | 2021-02-09 | 中牧实业股份有限公司 | 塞尼卡谷病毒结构蛋白抗原表位多肽及其应用 |
CN107513524B (zh) * | 2017-09-30 | 2021-02-09 | 中牧实业股份有限公司 | 一株猪塞内加谷病毒毒株及其应用 |
CN108467904B (zh) * | 2018-05-24 | 2021-11-19 | 华南农业大学 | 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用 |
CN109182278B (zh) * | 2018-10-12 | 2021-08-06 | 河南省动物疫病预防控制中心 | 塞尼卡谷病毒毒株及其应用 |
US20210403950A1 (en) * | 2018-11-13 | 2021-12-30 | Oncorus, Inc. | Encapsulated polynucleotides and methods of use |
CN109234464A (zh) * | 2018-11-23 | 2019-01-18 | 山东新希望六和集团有限公司 | 用于检测塞尼卡谷病毒的引物及探针、荧光定量pcr试剂盒及方法和应用 |
CN111733144A (zh) * | 2019-03-25 | 2020-10-02 | 金宇保灵生物药品有限公司 | 一种塞内卡病毒的纯化方法及病毒液的浓缩纯化方法 |
CN110229218B (zh) * | 2019-06-24 | 2020-12-01 | 中国动物疫病预防控制中心(农业农村部屠宰技术中心) | 检测塞内卡病毒抗体的试剂及其所用多肽 |
US20220249584A1 (en) * | 2019-07-19 | 2022-08-11 | Seneca Therapeutics, Inc. | Second generation seneca valley virus oncolytic therapy: compositions and methods thereof |
CN110923211A (zh) * | 2019-12-25 | 2020-03-27 | 哈药集团生物疫苗有限公司 | 塞内卡病毒分离株、塞内卡病毒病灭活疫苗及其制备方法 |
CN111286491A (zh) * | 2020-02-03 | 2020-06-16 | 河南省动物疫病预防控制中心 | 猪塞内卡病毒核酸标准物及其应用 |
CN111849925B (zh) * | 2020-07-06 | 2022-06-03 | 马忠仁 | 一种抗结肠癌疫苗及其制法 |
CN111798712B (zh) * | 2020-07-15 | 2021-10-29 | 周晓庆 | 噬菌体侵染细菌3d智能模拟方法 |
CN111944764A (zh) * | 2020-08-31 | 2020-11-17 | 信阳农林学院 | 一种表达猪塞内加谷病毒蛋白的细胞系、构建方法和应用 |
CN112390861A (zh) * | 2020-09-30 | 2021-02-23 | 信阳农林学院 | 表达猪塞内加谷病毒vp1蛋白的细胞系、构建方法和应用 |
CN117487006B (zh) * | 2023-12-29 | 2024-04-12 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 一种抗a型塞内卡病毒的单克隆抗体以及抗原表位及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
-
2004
- 2004-09-23 SG SG200809634-9A patent/SG149069A1/en unknown
- 2004-09-23 DK DK04789044.7T patent/DK1668025T3/da active
- 2004-09-23 CN CN200480030443XA patent/CN1875028B/zh not_active Expired - Lifetime
- 2004-09-23 CA CA002540177A patent/CA2540177A1/en not_active Abandoned
- 2004-09-23 BR BRPI0414810-0A patent/BRPI0414810A/pt not_active IP Right Cessation
- 2004-09-23 AU AU2004275832A patent/AU2004275832A1/en not_active Abandoned
- 2004-09-23 MX MXPA06003318A patent/MXPA06003318A/es unknown
- 2004-09-23 EP EP04789044.7A patent/EP1668025B1/en not_active Expired - Lifetime
- 2004-09-23 KR KR1020067008081A patent/KR20060103890A/ko not_active Application Discontinuation
- 2004-09-23 JP JP2006528260A patent/JP2007506434A/ja active Pending
- 2004-09-23 WO PCT/US2004/031504 patent/WO2005030139A2/en active Application Filing
-
2006
- 2006-03-21 IL IL174430A patent/IL174430A0/en unknown
- 2006-12-12 HK HK06113648.3A patent/HK1094583A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2004275832A1 (en) | 2005-04-07 |
JP2007506434A (ja) | 2007-03-22 |
WO2005030139A3 (en) | 2005-10-20 |
CA2540177A1 (en) | 2005-04-07 |
MXPA06003318A (es) | 2006-06-08 |
HK1094583A1 (en) | 2007-04-04 |
EP1668025A2 (en) | 2006-06-14 |
CN1875028B (zh) | 2012-07-04 |
IL174430A0 (en) | 2006-08-01 |
BRPI0414810A (pt) | 2006-11-14 |
CN1875028A (zh) | 2006-12-06 |
KR20060103890A (ko) | 2006-10-04 |
SG149069A1 (en) | 2009-01-29 |
WO2005030139A2 (en) | 2005-04-07 |
EP1668025A4 (en) | 2007-05-16 |
EP1668025B1 (en) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1668025T3 (da) | Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdom | |
DK2878297T3 (da) | Lægemidler til behandling og forebyggelse af fibrotiske sygdomme | |
NO20052049D0 (no) | Fremgangsmate og system til indentitetsgjenkjennelse | |
NO20043839L (no) | Havbunnsbasert intervensjonssystem, fremgangsmate for og komponeter i dette | |
IS8153A (is) | Ónæmisbælandi efnasambönd og efnablöndur | |
DK1668141T3 (da) | Fremgangsmåder til forbedring af planters tørketolerance og fremgangsmåder dertil | |
NO20040640L (no) | Anordning og fremgangsmate | |
DK1608842T3 (da) | System og fremgangsmåde til cementering med omvendt cirkulation | |
NO20053817D0 (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
DK1530972T3 (da) | Fremgangsmåde til screening for parasitpræparaters effektivitet i forebyggelse og kontrol af sygdomme | |
IS2878B (is) | Arípíprazól-samsett lyfjaform og aðferð | |
DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
DE602004016245D1 (de) | und Bildverarbeitungsverfahren | |
DK1511734T3 (da) | Forbindelser, præparater og fremgangsmåder | |
NO20032220D0 (no) | Löfteverktöy II og fremgangsmåte for anvendelse av samme | |
DE602004021212D1 (de) | Protokolldateiübertragungsgerät und Protokolldateiübertragungsverfahren | |
DK1725253T3 (da) | Medikamenter og fremgangsmåder til behandling af hovedpine | |
DK1620551T3 (da) | Phospholipase og fremgangsmåde til fremstilling deraf | |
DK1523323T3 (da) | Reagenser og fremgangsmåder til behandlinger i den glatte muskulatur | |
DK1791561T3 (da) | Hæmoragisk feline calicivirus, calicivirus-vaccine og fremgangsmåde til forebyggelse af calicivirus-infektion eller -sygdom | |
DK1667730T3 (da) | Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom | |
IS8497A (is) | Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma | |
IS8489A (is) | Umritunarstillar og aðferðir þeirra | |
NO20055778D0 (no) | Folgesystem og assosiert fremgangsmate |